Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 22Stomach Neoplasms 3Inflammatory Breast Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Malignant mesenchymal tumor 2Lymphoma 2Liver Neoplasms 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Esophageal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Neoplasms, Unknown Primary 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1

Interventions

Specimen Handling 17Magnetic Resonance Spectroscopy 15Gemcitabine 13Cisplatin 8Biopsy 8Radiotherapy 7Mitomycin 6Cystoscopy 6pembrolizumab 5Trastuzumab 5Paclitaxel 5Fluorouracil 5cabozantinib 4atezolizumab 4Radiation 4erdafitinib 3dehydroftorafur 3Transurethral Resection of Bladder 3Sunitinib 3Sorafenib 3Platinum 3Nivolumab 3Mitozytrex 3Gene Expression Profiling 3Fluorodeoxyglucose F18 3Carboplatin 31,2-diaminocyclohexaneplatinum II citrate 3valrubicin 2tipifarnib 2sapanisertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Urinary Bladder Neoplasms × Epirubicin × Clear all
NCT01094964 2013-08-12

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
242 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡